Re-emergence of vaccine-derived polio in the demographic Republic of Congo: Causes and consequences
Authors:
- Malik Olatunde OduoyeMOMalik Olatunde Oduoye
- Samuel Chinonso UbechuSUSamuel Chinonso Ubechu
- Marina Ramzy MouridMMMarina Ramzy Mourid
- Ahmad Ibrahim AhmadAAAhmad Ibrahim Ahmad
- Abdullahi Adeyemi AdegokeAAAbdullahi Adeyemi Adegoke
- Umulkhairah Onyioiza AramaUmulkhairah Onyioiza Arama
- Muhammad FurqanMFMuhammad Furqan
- Saiyad AliSASaiyad Ali
- Bashiru Muhammad AuwalBABashiru Muhammad Auwal
- F.N.U. FarihaFFF.N.U. Fariha
- Ankini MukherjeeAMAnkini Mukherjee
- Aymar AkilimaliAAAymar Akilimali
Open Access
- 24 September 2024
- journal article
- research article
- Published by Elsevier in New Microbes and New Infections
- Vol. 62, 101489
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Halting vaccine-derived poliovirus circulation: the novel type 2 oral vaccine might not be enoughThe Lancet Global Health, 2023
- Vaccine-derived poliovirus serotype 2 outbreaks and response in the Democratic Republic of the Congo, 2017–2021Vaccine, 2023
- Assessing country compliance with circulating vaccine-derived poliovirus type 2 outbreak response standard operating procedures: April 2016 to December 2020Vaccine, 2023
- Genetic and epidemiological description of an outbreak of circulating vaccine-derived polio-virus type 2 (cVDPV2) in Angola, 2019–2020Vaccine, 2023
- Effectiveness of a new vaccine for outbreak response and the increasingly complicated polio endgameThe Lancet Global Health, 2022
- Exploring public perceptions of vaccine-derived poliovirus and a novel oral polio vaccine in the Democratic Republic of the Congo, Kenya, and NigeriaVaccine, 2022
- Concurrent outbreaks of circulating vaccine-derived poliovirus types 1 and 2 affecting the Republic of the Philippines and Malaysia, 2019–2021Vaccine, 2022
- Global oral poliovirus vaccine stockpile management as an essential preparedness and response mechanism for type 2 poliovirus outbreaks following global oral poliovirus vaccine type 2 withdrawalVaccine, 2022
- Risk factors for the spread of vaccine-derived type 2 polioviruses after global withdrawal of trivalent oral poliovirus vaccine and the effects of outbreak responses with monovalent vaccine: a retrospective analysis of surveillance data for 51 countries in AfricaThe Lancet Infectious Diseases, 2022
- Polio immunity and the impact of mass immunization campaigns in the Democratic Republic of the CongoVaccine, 2017